DK3397619T3 - Salve - Google Patents

Salve Download PDF

Info

Publication number
DK3397619T3
DK3397619T3 DK16828990.8T DK16828990T DK3397619T3 DK 3397619 T3 DK3397619 T3 DK 3397619T3 DK 16828990 T DK16828990 T DK 16828990T DK 3397619 T3 DK3397619 T3 DK 3397619T3
Authority
DK
Denmark
Prior art keywords
ointment
Prior art date
Application number
DK16828990.8T
Other languages
English (en)
Inventor
Yoshihiro Murakami
Hitoshi Matsushita
Kengo Matsumoto
Minoru Okada
Yohei Yuki
Noriyuki Koyama
Naohiko Kanai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK3397619T3 publication Critical patent/DK3397619T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/4211,3-Oxazoles, e.g. pemoline, trimethadione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK16828990.8T 2015-12-28 2016-12-27 Salve DK3397619T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015256784 2015-12-28
PCT/JP2016/088843 WO2017115780A1 (en) 2015-12-28 2016-12-27 Ointment

Publications (1)

Publication Number Publication Date
DK3397619T3 true DK3397619T3 (da) 2020-08-24

Family

ID=57851287

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16828990.8T DK3397619T3 (da) 2015-12-28 2016-12-27 Salve

Country Status (16)

Country Link
US (3) US10588893B2 (da)
EP (1) EP3397619B1 (da)
JP (3) JP6873128B2 (da)
KR (2) KR102643824B1 (da)
CN (1) CN108473448A (da)
AU (1) AU2016382036B2 (da)
CA (1) CA3009734A1 (da)
DK (1) DK3397619T3 (da)
ES (1) ES2811849T3 (da)
HK (1) HK1255187A1 (da)
MY (1) MY197975A (da)
PH (1) PH12018501346A1 (da)
SA (1) SA518391908B1 (da)
SG (2) SG11201805364TA (da)
TW (1) TWI726027B (da)
WO (1) WO2017115780A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11414391B2 (en) 2018-04-04 2022-08-16 Otsuka Pharmaceutical Co., Ltd. Oxazole compound crystal
JP7051968B2 (ja) * 2019-10-09 2022-04-11 大塚製薬株式会社 オキサゾール化合物結晶

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6419963B1 (en) * 2001-04-22 2002-07-16 Sarfaraz K Niazi Composition and method for the treatment of diaper rash using natural products
US7655717B2 (en) * 2002-07-17 2010-02-02 Mary J. Goulbourne Ointment composition for treating decubitus ulcers and methods for its making and its use
TW200418516A (en) * 2003-02-21 2004-10-01 Shionogi & Co Droplet dispersed ointment
MY153720A (en) * 2005-11-15 2015-03-13 Otsuka Pharma Co Ltd Oxazole compound and pharmaceutical composition
ES2478845T3 (es) * 2008-10-08 2014-07-23 Takata Seiyaku Co., Ltd. Preparación de tacrolimus para aplicaciones externas
GB0907413D0 (en) * 2009-04-29 2009-06-10 Equateq Ltd Novel methods
JP5965187B2 (ja) * 2012-03-30 2016-08-03 小林製薬株式会社 油性軟膏剤
WO2014034958A1 (en) 2012-08-30 2014-03-06 Otsuka Pharmaceutical Co., Ltd. Method for producing oxazole compound

Also Published As

Publication number Publication date
WO2017115780A1 (en) 2017-07-06
AU2016382036B2 (en) 2021-02-04
NZ743851A (en) 2021-09-24
US10588893B2 (en) 2020-03-17
US20220117944A1 (en) 2022-04-21
HK1255187A1 (zh) 2019-08-09
KR20240034867A (ko) 2024-03-14
US20200171006A1 (en) 2020-06-04
SG11201805364TA (en) 2018-07-30
JP2023058571A (ja) 2023-04-25
US20190000810A1 (en) 2019-01-03
CA3009734A1 (en) 2017-07-06
CN108473448A (zh) 2018-08-31
AU2016382036A1 (en) 2018-07-12
ES2811849T3 (es) 2021-03-15
JP6873128B2 (ja) 2021-05-19
SA518391908B1 (ar) 2022-06-05
MY197975A (en) 2023-07-25
SG10201912634QA (en) 2020-02-27
JP2019503989A (ja) 2019-02-14
PH12018501346B1 (en) 2019-02-18
KR20180097672A (ko) 2018-08-31
KR102643824B1 (ko) 2024-03-07
EP3397619B1 (en) 2020-07-29
TW201729806A (zh) 2017-09-01
TWI726027B (zh) 2021-05-01
JP2021107437A (ja) 2021-07-29
PH12018501346A1 (en) 2019-02-18
EP3397619A1 (en) 2018-11-07

Similar Documents

Publication Publication Date Title
FIC20230006I1 (fi) Vutrisiraani
DK3283625T3 (da) Nukleasemedieret genomeditering
DK3331869T3 (da) Muscarinagonister
DK3305788T3 (da) Janus-kinase-hæmmer
DK3265421T3 (da) Doseringssystem
DK3277719T3 (da) Polypeptider
DK3360890T3 (da) Genterapi
DK3331528T3 (da) Muskarinagonister
DK3331529T3 (da) Muskarinagonister
KR20180084915A (ko) 구조체
DK3270930T3 (da) Præeklampsi
DK3296597T3 (da) Krydshovedmotor
DK3394281T3 (da) Gærcelle
DK3292136T3 (da) Penicillin-g-acylaser
DE112015006486A5 (de) Inkubationsrinne
DK3318308T3 (da) Badmintonketsjer
DK3274482T3 (da) Stenborsknop
DE112016005599A5 (de) Strahlungsgrill
DE112015005906A5 (de) Gurtschlossbringer
ES1140083Y (es) Descompatactador tetrafunción
DE102015206660A8 (de) Plattenaufteilanlage
DK3397619T3 (da) Salve
TR201512960A1 (tr) Topi̇kal formülasyonlar
DE112016001124A5 (de) Spannschutz
DE102015000551A8 (de) Rotationszerstäuberturbine